Robert Baron insider trades: Hemobiotech (HMBT.OB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 20, 2006 | HMBT.OB | ↑ Buy | 5,000 | $1.79 | $9K | Direct | Mar 21, 2006 (1d) |
| Feb 23, 2006 | HMBT.OB | ↑ Buy | 5,000 | $1.95 | $10K | Direct | Feb 27, 2006 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Robert Baron's insider trades
Robert Baron is a director at Hemobiotech (HMBT.OB). Since Feb 23, 2006, Robert has reported 2 open-market purchases worth $19K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (15 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HMBT.OB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.